Monthly Archive: June 2015

Jun 29

Men with rheumatoid arthritis (RA)

Men with rheumatoid arthritis (RA) have double the rate of all-cause mortality and triple the rate of respiratory-related death compared with the general population without RA, with cardiovascular disease (CVD)-related mortality being the leading cause of death, suggests new research published online in Arthritis Care and Research.

Jun 29

The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD)

The first ESC recommendations for patients with cardiac arrhythmias and chronic kidney disease (CKD) were presented June 24 at EHRA EUROPACE – CARDIOSTIM 2015 and published in EP Europace. The paper outlines how to stage and monitor CKD; the association between CKD and hypertension, heart failure and atrial fibrillation; how CKD affects management of patients …

Continue reading »

Jun 28

The European Commission (EC)

The European Commission (EC) has approved edoxaban for high-risk patients with nonvalvular atrial fibrillation and for the treatment and prevention of deep-venous thrombosis (DVT) and pulmonary embolism (PE).

Jun 28

he study was presented at the European Society of Hypertension (ESH) 2015 Scientific Sessions.

A real-world study of more than 4000 patients seen in a blood-pressure clinic did not find a J-shaped relationship in which patients with a low diastolic blood pressure were at increased risk of dying from all causes or from cardiovascular causes. The study was presented at the European Society of Hypertension (ESH) 2015 Scientific Sessions.

Jun 27

A single-blind randomized multicenter trial published online June 24 in the New England Journal of Medicine suggests that one year after femoropopliteal-artery angioplasty for symptomatic disease

A single-blind randomized multicenter trial published online June 24 in the New England Journal of Medicine suggests that one year after femoropopliteal-artery angioplasty for symptomatic disease, patients treated with a paclitaxel-coated balloon showed superior target-vessel patency, and their results were “noninferior” for a composite safety end point that included amputation and limb-related death, in comparison …

Continue reading »

Jun 27

Chronically elevated blood pressure from young adulthood to middle age is associated with systolic and diastolic dysfunction in a group of healthy middle-aged adults

Chronically elevated blood pressure from young adulthood to middle age is associated with systolic and diastolic dysfunction in a group of healthy middle-aged adults, reported a new analysis of the Coronary Artery Risk Development in Young Adults (CARDIA) study. The findings are published in the June 30 issue of the Journal of the American College …

Continue reading »

Jun 26

The European Society of Cardiology (ESC)

The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation in a position paper presented at EHRA EUROPACE – CARDIOSTIM 2015.

Jun 26

For older patients with a low left ventricular ejection fraction (LVEF)

For older patients with a low left ventricular ejection fraction (LVEF) following MI, less than one in 10 receive an implantable cardioverter defibrillator (ICD) within 1 year after hospital discharge, despite clinical guidelines recommending primary-prevention ICD use in these patients, suggests a new study published in the June 23 issue of the Journal of the …

Continue reading »

Jun 25

For warfarin-treated patients with atrial fibrillation undergoing an elective surgery or invasive procedure, perioperative bridging with low-molecular-weight heparin (LMWH)

For warfarin-treated patients with atrial fibrillation undergoing an elective surgery or invasive procedure, perioperative bridging with low-molecular-weight heparin (LMWH) was not associated with a reduction in stroke, systemic embolism, or transient ischemic attack compared with no bridging but did significantly increase the risk of bleeding, reported a new study presented at the International Society for …

Continue reading »

Jun 25

The Cardiorespiratory Fitness on Arrhythmia Recurrence in Obese Individuals with Atrial Fibrillation (CARDIO-FIT)

The Cardiorespiratory Fitness on Arrhythmia Recurrence in Obese Individuals with Atrial Fibrillation (CARDIO-FIT) study suggests that cardiorespiratory fitness (CRF) not only helps with relieving symptoms of atrial fibrillation (AF), but it also predicts recurrence in patients who are obese. The findings were presented at the European Heart Rhythm Association (EHRA) EUROPACE-CARDIOSTIM 2015 meeting.

Older posts «